Profiel
Randall E.
Woods was the founder of Sequel Pharmaceuticals, Inc. founded in 2007, where he held the titles of President, Chief Executive Officer & Director.
Currently, he is the Chief Executive Officer & Director at Tychan Pte Ltd. since 2021, Chairman at Sorbent Therapeutics, Inc. since 2012, and Director at Eden Woods Investments LLC.
Mr. Woods has an undergraduate degree from Ball State University (Indiana) in 1973 and an MBA degree from Western Michigan University.
Actieve functies van Randall E. Woods
| Bedrijven | Functie | Begin |
|---|---|---|
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Voorzitter | 19-04-2012 |
Eden Woods Investments LLC
Eden Woods Investments LLC Financial ConglomeratesFinance Provides investment services | Directeur/Bestuurslid | - |
Tychan Pte Ltd.
Tychan Pte Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Algemeen Directeur | 01-01-2021 |
Eerdere bekende functies van Randall E. Woods
| Bedrijven | Functie | Einde |
|---|---|---|
| ARENA PHARMACEUTICALS | Directeur/Bestuurslid | 12-06-2020 |
Sequel Pharmaceuticals, Inc.
Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Engages in the development of cardiovascular drug | Oprichter | 01-09-2011 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Algemeen Directeur | 01-09-2007 |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Algemeen Directeur | 01-07-2003 |
Boehringer Mannheim Pharmaceuticals Corp. | President | 01-03-1996 |
Opleiding van Randall E. Woods
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Health Technology |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Health Technology |
Ball State University (Indiana)
Ball State University (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Boehringer Mannheim Pharmaceuticals Corp. | |
Sequel Pharmaceuticals, Inc.
Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Engages in the development of cardiovascular drug | Retail Trade |
Eden Woods Investments LLC
Eden Woods Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Tychan Pte Ltd.
Tychan Pte Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
















